APA (7th ed.) Citation

Abi-Dargham, A., Kegeles, L., & Slifstein, M. (2018). 43.4 THE ROLE OF MOLECULAR IMAGING IN GUIDING DRUG DEVELOPMENT. Schizophrenia bulletin, 44(suppl_1), S71. https://doi.org/10.1093/schbul/sby014.182

Chicago Style (17th ed.) Citation

Abi-Dargham, Anissa, Lawrence Kegeles, and Mark Slifstein. "43.4 THE ROLE OF MOLECULAR IMAGING IN GUIDING DRUG DEVELOPMENT." Schizophrenia Bulletin 44, no. suppl_1 (2018): S71. https://doi.org/10.1093/schbul/sby014.182.

MLA (9th ed.) Citation

Abi-Dargham, Anissa, et al. "43.4 THE ROLE OF MOLECULAR IMAGING IN GUIDING DRUG DEVELOPMENT." Schizophrenia Bulletin, vol. 44, no. suppl_1, 2018, p. S71, https://doi.org/10.1093/schbul/sby014.182.